Altimmune
ALT
36 hedge funds and large institutions have $42.5M invested in Altimmune in 2015 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 10 closing their positions.
13% less capital invested
Capital invested by funds: $48.8M → $42.5M (-$6.32M)
16% less funds holding
Funds holding: 43 → 36 (-7)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
33% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 9
67% less call options, than puts
Call options by funds: $1K | Put options by funds: $3K
70% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 10
Top Buyers
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$3.75M |
| 2 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$291K |
| 3 |
M&T Bank
Buffalo,
New York
|
+$99.6K |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$42.4K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$21.4K |
Top Sellers
| 1 |
JCI
Jet Capital Investors
New York
|
-$4.21M |
| 2 |
SC
Sophrosyne Capital
New York
|
-$903K |
| 3 |
JGC
J. Goldman & Co
New York
|
-$295K |
| 4 |
SM
Scoggin Management
New York
|
-$268K |
| 5 |
Walleye Trading
New York
|
-$248K |
ALT Hedge Fund Activity: Q1 2015 in Review
36 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Altimmune (ALT) for Q1 2015, worth a combined $42.5M — down 13% from $48.8M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of ALT and 3 opened new positions — a net loss of 7 holders — while 9 trimmed existing stakes and 6 added.
The largest buyer was Hudson Bay Capital Management, adding an estimated $3.75M. The largest seller was Jet Capital Investors, exiting entirely with an estimated $4.21M sold.
- 36 institutional investors held Altimmune (ALT) as of Q1 2015, down from 43 in Q4 2014.
- Funds reported $42.5M of Altimmune stock for Q1 2015, down 13% quarter-over-quarter.
- 3 funds opened new Altimmune positions in Q1 2015 and 10 closed out, a net change of -7 holders.
- The largest Altimmune buyer in Q1 2015 was Hudson Bay Capital Management, an estimated $3.75M added.
- The largest Altimmune seller in Q1 2015 was Jet Capital Investors, an estimated $4.21M sold.
Based on aggregated 13F filings for Q1 2015.